A PYMNTS Company

US: Fifth Circuit scraps $340M EDTX antitrust verdict

By  |  December 6, 2016

An appellate court has shot down the idea that patent infringement can give rise to antitrust liability, and with it a $340 million jury verdict.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    Friday’s ruling from the US Court of Appeals for the Fifth Circuit hands a big win to Becton Dickinson in its 15-year legal dispute with Retractable Technologies over safety syringes. Safety syringes are designed to prevent the transmission of blood-borne diseases such as AIDS via accidental needle prick.

    Retractable Technologies won a $5 million patent infringement verdict against Becton Dickinson in 2010. It subsequently persuaded an Eastern District of Texas jury that the infringement was part of an attempted monopolization campaign that also included false advertising and a predatory scheme to taint the market for certain syringes. The jury awarded $113.5 million, which then-Chief Judge Leonard Davis trebled.

    But Fifth Circuit Judge Edith Jones concluded for a unanimous panel that while patent infringement may be a form of unfair competition, it cannot be labeled anti-competitive.

    Full Content: Inside Counsel

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.